Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Outcome of Refractory to Conventional And/or Biologic Treatment Adult Still's Disease Following Canakinumab Treatment: Countrywide Data in 50 Patients.

K. Laskari, M. G. Tekonidu,C. Katsiari,P. Athanassiou,D. Dimopoulou,C. Gerodimos,C. Salamaliki,C. Papagoras,L. Settas,D. Vassilopoulos,P. V. Voulgari,M. Zakalka,A. Georgiadis, G. Gkoni,D. Daoussis,T. Dimitroulas, C. Iliou,I Kallitsakis,E. P. Grika,C. Mavragani,D. Pikazis, J. Raftakis, T. Sarikoudis,N. Kougkas, D. Soukera,E. Theodorou,P. Tsatsani, E. Tsiakou, P. Vlachoyiannopoulas,G. Vosvotekas,P. P. Sfikakis

Seminars in Arthritis and Rheumatism（2021）

Cited 19|Views19
No score
Key words
Refractory still's disease,Il-1 inhibition,canakinumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined